CHICAGO, May 3, 2017 /PRNewswire/ -- Chicago based Rheoxtech LLC has appointed David W.J. Smithas its first President. David has 30 years' experience in founding, developing and providing successful exits for medical device businesses and their investors. He originally started his career in the UK, before moving to the US and immersing himself
Rheoxtech was founded by cardiac surgeon Neil J. Thomas MD and serial entrepreneur Gintaras Vaisnys. It is building on the pioneering work of Dr Thomas, a longtime proponent of controlling cardiac oxygen re-exposure as part of the protection of the heart during surgery, particularly for patients that are hemodynamically unstable and those in cardiogenic shock.
Mr. Vaisnys commented, "We are delighted to attract someone of David's caliber to this critical role. He has exactly the right blend of project management, fund raising and business development experience we were seeking to drive outstanding shareholder returns."
Rheoxtech LLC is a closely held private company, committed to the development of devices for protected reperfusion in percutaneous coronary intervention (PCI) and cardiac surgery.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/rheoxtech-appoints-david-wj-smith-as-president-300450477.html
SOURCE Rheoxtech LLC
Subscribe to our Free Newsletters!
Fallopian tube cancer is a form of gynecologic cancer arising in the fallopian tubes, which are ...
Cushing syndrome is a collection of symptoms caused due to excessive amount of cortisol in the body ...
CAR T-cell therapy is a type of gene therapy where the patient's T-lymphocytes are genetically ...View All